ONMD Class A OneMedNet Corp - Class A Common Stock
NASDAQ · Health Care · View on SEC EDGAR ↗ close Oct 2, 2026 10-K/10-Q Aug 14, 2026ONMD Stock Snapshot Price, market cap, P/E, EPS, ROE, debt/equity, 52-week range
ONMD Stock Price Chart Daily OHLCV with technical indicators — pan, zoom, and customize your view
Bar granularity adapts to the selected period — hover the chart to see open/high/low/close for a bar.
10-Year Performance Revenue, net income, margins and EPS trends
Valuation P/E, P/S, P/B, EV/EBITDA ratios — is the stock expensive or cheap?
| Metric | 5Y trend | ONMD | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| P/B (MRQ) | -88.4 | · | · | · |
Peer median is calculated on a standardized basis per metric and may not always match the TTM/MRQ basis shown for this stock.
Profitability Gross, operating and net margins; ROE, ROA, ROIC
Not enough fundamentals data to compute this ratio group yet.
Financial Health Debt, liquidity, solvency — balance sheet strength
| Metric | 5Y trend | ONMD | 5Y avg | Peer Median | Verdict |
|---|---|---|---|---|---|
| Current Ratio (MRQ) | 0.3 | · | · | · |
Growth Revenue, EPS and net income growth: YoY, 3Y CAGR, 5Y CAGR
Not enough fundamentals data to compute this ratio group yet.
Capital Efficiency Asset turnover, inventory turnover, receivables turnover
Not enough fundamentals data to compute this ratio group yet.
value · ≈ 5Y avg · industry median · verdict relative to median
Full Fundamentals All metrics by year — income statement, balance sheet, cash flow
We don't have SEC filings for this ticker yet.
Income Statement
| Metric | Trend | Q2 2026 |
|---|---|---|
| Revenue | $292.0K | |
| Cost of Revenue | $857.0K | |
| Gross Profit | $-565.0K | |
| R&D Expense | $324.0K | |
| SG&A Expense | $981.0K | |
| Operating Expenses | $2M | |
| Operating Income | $-2M | |
| Other Non-op | $2.0K | |
| Net Income | $-2M | |
| EPS (Basic) | $-0.04 | |
| EPS (Diluted) | $-0.04 | |
| Shares (Basic) | 58,019,837 | |
| Shares (Diluted) | 58,019,837 | |
| EBITDA | $-2M |
Balance Sheet
| Metric | Trend | Q2 2026 |
|---|---|---|
| Cash & Equivalents | $358.0K | |
| Receivables | $664.0K | |
| Prepaid Expense | $291.0K | |
| Current Assets | $1M | |
| PP&E (Net) | $51.0K | |
| Total Assets | $1M | |
| Accounts Payable | $3M | |
| Current Liabilities | $5M | |
| Total Liabilities | $5M | |
| Long-term Debt | $132.0K | |
| Common Stock | $5.0K | |
| Paid-in Capital | $106M | |
| Retained Earnings | $-109M | |
| Treasury Stock | $529.0K | |
| Stockholders' Equity | $-4M | |
| Liabilities + Equity | $1M | |
| Shares Outstanding | 57,721,343 |
Cash Flow
| Metric | Trend | Q2 2026 |
|---|---|---|
| Stock-based Comp | $463.0K | |
| Operating Cash Flow | $-2M | |
| CapEx | $9.0K | |
| Investing Cash Flow | $56.0K | |
| Financing Cash Flow | $2M | |
| Net Change in Cash | $125.0K |
Profitability
| Metric | Trend | Q2 2026 |
|---|---|---|
| Gross Margin | -193.5% | |
| Operating Margin | -774.3% | |
| Net Margin | -743.8% | |
| EBITDA Margin | -774.3% | |
| ROA | -117.4% | |
| ROE | 59.0% |
Liquidity & Solvency
| Metric | Trend | Q2 2026 |
|---|---|---|
| Current Ratio | 0.3 | |
| Quick Ratio | 0.2 |
Efficiency
| Metric | Trend | Q2 2026 |
|---|---|---|
| Asset Turnover | 0.2 | |
| Receivables Turnover | 0.6 |
Per Share
| Metric | Trend | Q2 2026 |
|---|---|---|
| Book Value / Share | $-0.06 | |
| Revenue / Share | $0.01 | |
| Cash / Share | $0.01 | |
| EPS (TTM) | $-0.15 |
Valuation (TTM)
| Metric | Trend | Q2 2026 |
|---|---|---|
| Revenue TTM | $1M | |
| Net Income TTM | $-9M | |
| Market Cap | $41M | |
| P/E | -4.7 | |
| P/S | 28.2 | |
| P/B | -11.7 | |
| Earnings Yield | -21.1% |
Most recent period on the left · null values shown as ·
Financial Statements Income statement, balance sheet, cash flow — annual, last 5 years
Not enough fundamentals data to build this statement yet.
Not enough fundamentals data to build this statement yet.
Not enough fundamentals data to build this statement yet.
Institutional owners (13F) 24 filers · $12.3M total · As of June 30, 2026
Institutions that report holding this stock in their quarterly SEC Form 13F. Long positions only; a single filer may appear twice for separate option legs. Large offsetting put/call legs typically reflect market-making or hedged inventory, not directional conviction.
| New positions | Exited positions | Increased | Decreased | Net shares change |
|---|---|---|---|---|
| 6 (0 vs prior Q) | 4 (-3 vs prior Q) | 5 (-1 vs prior Q) | 4 (+3 vs prior Q) | +7.2M |
Compared to Q1 2026. SEC Form 13F filings are due within 45 days of quarter-end plus a short buffer for late filers — quarters still inside that window are skipped in favor of the most recent fully-reported pair.
| Institution | Value | Shares | % of tracked 13F | Type |
|---|---|---|---|---|
| Savant Capital, LLC | $5,142,989 | 7,219,243 | 41.86% | Shares |
| EXENCIAL WEALTH ADVISORS, LLC | $4,009,347 | 3,644,861 | 32.63% | Shares |
| VANGUARD GROUP INC | $1,431,436 | 1,301,306 | 11.65% | Shares |
| VANGUARD CAPITAL MANAGEMENT LLC | $819,221 | 1,152,210 | 6.67% | Shares |
| GEODE CAPITAL MANAGEMENT, LLC | $237,709 | 334,332 | 1.93% | Shares |
| VANGUARD FIDUCIARY TRUST CO | $97,909 | 137,706 | 0.80% | Shares |
| BlackRock, Inc. | $86,017 | 120,980 | 0.70% | Shares |
| STATE STREET CORP | $82,974 | 116,700 | 0.68% | Shares |
| DISCOVERY CAPITAL MANAGEMENT, LLC / CT | $79,811 | 112,252 | 0.65% | Shares |
| PNC Financial Services Group, Inc. | $73,469 | 103,332 | 0.60% | Shares |
| OpenArc Corporate Advisory, LLC | $69,261 | 97,413 | 0.56% | Shares |
| NORTHERN TRUST CORP | $33,300 | 46,835 | 0.27% | Shares |
| CAPTRUST FINANCIAL ADVISORS | $23,179 | 32,600 | 0.19% | Shares |
| Ashton Thomas Private Wealth, LLC | $18,910 | 26,596 | 0.15% | Shares |
| TORONTO DOMINION BANK | $16,779 | 23,599 | 0.14% | Shares |
| NEUBERGER BERMAN GROUP LLC | $13,867 | 19,504 | 0.11% | Shares |
| UBS Group AG | $11,472 | 16,135 | 0.09% | Shares |
| Procyon Advisors, LLC | $9,821 | 13,814 | 0.08% | Shares |
| RAYMOND JAMES FINANCIAL INC | $8,603 | 12,100 | 0.07% | Shares |
| MORGAN STANLEY | $8,405 | 11,821 | 0.07% | Shares |
| COMMONWEALTH EQUITY SERVICES, LLC | $7,820 | 11,000 | 0.06% | Shares |
| Tower Research Capital LLC (TRC) | $3,371 | 4,741 | 0.03% | Shares |
| SBI Securities Co., Ltd. | $112 | 157 | 0.00% | Shares |
| HRT FINANCIAL LP | $11 | 15,628 | 0.00% | Shares |
Company insiders 1 insider · 1 officers · 1 directors
| Insider | Role | Last activity | Shares owned | Buys 12m | Sells 12m | Net 12m |
|---|---|---|---|---|---|---|
| Jeffrey Yu | Chief Medical Officer | Sept. 10, 2026 P | 8,923,267 | 1 | 0 | $90,000 |
Insiders from SEC Form 3/4/5 filings; net = open-market P/S only
ETF ownership Held by 3 ETFs
Weight reflects direct equity holdings (N-PORT) only; leveraged or derivative-based funds may hold additional swap exposure not shown.
Latest News Recent headlines mentioning this company
My Metrics Your personal watchlist — selected rows from Full Fundamentals
Pick the metrics that matter to you — click the + next to any row in Full Fundamentals above.
Your selection is saved and follows you across all tickers.